Home › Trial NCT04221438
Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement
- Trial IDNCT04221438
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorECOG-ACRIN Cancer Research Group
- Enrollment3
- Start date2021-09-22
- ConditionsMelanoma of Unknown Primary · Metastatic Malignant Neoplasm in Lymph Node · Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 · Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 · Pathologic Stage IIID Cutaneous Melanoma AJCC v8 · Recurrent Cutaneous Melanoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.